Clinical Research Directory
Browse clinical research sites, groups, and studies.
4 clinical studies listed.
Filters:
Tundra lists 4 mRNA Vaccine clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.
This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.
NCT07418229
Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine
To evaluate the safety of Sinovac RSV mRNA among participants aged ≥18 years
Gender: All
Ages: 18 Years - Any
Updated: 2026-02-18
1 state
NCT07400003
Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine
This clinical trial included two parts, Part A and Part B. The goal of Part A is to evaluate the safety and preliminary immunogenicity of the lyophilized herpes zoster virus mRNA vaccine (HZ mRNA vaccine) in healthy populations aged 40 years and older. The goal of Part B is to select the optimal dosage and schedule in healthy populations aged 50 years and older to support next further study.
Gender: All
Ages: 40 Years - Any
Updated: 2026-02-10
NCT07100210
A Clinical Trial Evaluating IL-22BP/LNP Compound in Refractory Malignant Solid Tumors for Safety, Tolerability and Activity
This study aims to investigate the safety and efficacy of the IL-22BP/LNP compound in patients with refractory malignant solid tumors, such as advanced soft tissue sarcoma, advanced head and neck squamous cell carcinoma, and malignant melanoma, who have failed second-line treatment, have advanced recurrence or metastatic malignant solid tumors.
Gender: All
Ages: 18 Years - 70 Years
Updated: 2025-12-29
1 state
NCT07040943
Clinical Trial of IL - 22BP Safety, Tolerability, and Antitumor Activity in Refractory Solid Tumors.
This study aims to investigate the safety and efficacy of the IL-22BP in patients with refractory malignant solid tumors.
Gender: All
Ages: 18 Years - 70 Years
Updated: 2025-07-01
1 state